News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Compugen Ltd. (CGEN) To Present Immune Checkpoint Related Research At Two Scientific Conferences



7/24/2014 11:22:32 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Compugen Ltd. (NASDAQ: CGEN) today announced that it will present aspects of its immune checkpoint related research at two upcoming scientific conferences. On August 11, John Hunter, PhD, Site Head & Vice President, Antibody Research & Development at Compugen USA, Inc., will present at the Immunotherapies and Vaccines Summit (ImVacs) being held from August 11-14, in Boston, MA.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES